CD23
$295.00 – $1,507.00
Description
Product Description
CD23 is a 45 kDa glycoprotein that acts as a receptor for IgE. It is expressed by interleukin-4 activated B-lymphocytes, by activated macrophages, and by a proportion of follicular dentritic cells. CD23 has been shown to be useful for the differentiation of small lymphocytic lymphomas and mantle cell lymphoma.15
Specifications
Specifications
| Weight | N/A |
|---|---|
| Dimensions | N/A |
| Intended Use | |
| Species Reactivity | |
| Source | |
| Clone | |
| Isotype | |
| Antigen | |
| Localization | |
| Positive Control | Follicular lymphoma or tonsil (mantle cell lymphomas are generally negative) |
Datasheets & SDS
| Download CE Marked IVD Datasheet |
| Download IVD Datasheet Without CE Mark |
| Download RUO Datasheet |
| Download SDS Sheet |
Browse more documents for this product (IFUs, datasheets, translations, SDS, and more).
Regulatory Notice: Biocare’s IVD-labeled products comply with US-FDA and European IVDD regulation. Other regions may have additional requirements for such labeling, please contact your local distributor.
References
1. Jin MK, et al. Histopathology. 2011 Mar; 58(4):586-92.
2. Akatsuka N, et al. Auris Nasus Larynx. 2011 Jun; 38(3):362-6.
3. Malik A, et al. J Cancer Res Ther. 2012 Apr-Jun; 8(2):306-7.
Reviews (0)
Be the first to review “CD23”
You must be logged in to post a review.
![(L) Anaplastic large cell lymphoma and (R) Lung adenocarcinoma stained with ALK antibody [5A4]](https://biocare.net/wp-content/uploads/3041-247x296.jpg)
Reviews
There are no reviews yet.